Molecular landscape of thymic epithelial tumors
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Seminars in Diagnostic Pathology
- Vol. 39 (2) , 131-136
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Insulin-Like Growth Factor-1 Receptor Expression in Thymic MalignanciesJournal of Thoracic Oncology, 2010
- Insulin‐like growth factor‐1 receptor and phosphorylated AKT‐serine 473 expression in 132 resected thymomas and thymic carcinomasCancer, 2010
- Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group StudyJournal of Thoracic Oncology, 2010
- Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and ThymomasClinical Cancer Research, 2009
- Identification of the TFII-I family target genes in the vertebrate genomeProceedings of the National Academy of Sciences, 2008
- c-Kit—A hematopoietic cell essential receptor tyrosine kinaseThe International Journal of Biochemistry & Cell Biology, 2007
- Thymic carcinoma with epidermal growth factor receptor gene mutationsLung Cancer, 2006
- Overexpression of KIT (CD117) in Chromophobe Renal Cell Carcinoma and Renal OncocytomaAmerican Journal of Clinical Pathology, 2004
- Tyrosine kinase receptor expression in thymomasJournal of Cancer Research and Clinical Oncology, 2004
- Primary thymic carcinomaThe Annals of Thoracic Surgery, 2002